stockrow
Friday 6 November 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024.
- Revenue
- +18.6%
- EPS
- +50.9%
- Free cash flow
- +146.6%
- Total debt
- +0.99%
Quarter to September 2026, against a year earlier
31.69
0.53
−1.64%
Follow KIDS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.04 | 1.82 | 1.54 | 1.76 | |
P/FCF ratio |
500.85 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
119.38 | 495.75 | (114.35) | 40.26 | |
P/B ratio |
1.59 | 1.34 | 1.11 | 1.20 | |
Price to Tangible BV |
3.66 | 3.10 | 2.56 | 2.61 | |
EV/Sales |
2.24 | 2.02 | 1.74 | 1.91 | |
EV/EBITDA |
729.40 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
47.28 | 68.81 | (106.07) | (92.94) | |
EV/FCF |
550.11 | (129.34) | (28.67) | (24.95) | |
Quick Ratio |
1.88 | 2.06 | 2.23 | 2.53 | |
Current Ratio |
4.55 | 4.78 | 5.21 | 5.55 | |
Net Debt/EBITDA |
26.36 | 30.33 | (17.79) | (154.81) | |
Debt/Assets |
19.22% | 19.09% | 19.39% | 19.10% | |
Debt/Equity |
0.29 | 0.28 | 0.29 | 0.28 | |
Asset Turnover |
0.53 | 0.50 | 0.50 | 0.48 | |
Operating CF/Net income |
(0.76) | (0.13) | 0.31 | (1.02) | |
Capex/Depreciation |
(0.47) | (0.71) | (0.31) | (0.08) | |
Interest Coverage |
(1.61) | (1.61) | (3.97) | (4.23) | |
Research and Development Expense of Revenue |
3.39% | 3.30% | 3.76% | 3.67% | |
Selling, General and Administrative Expense of Revenue |
75.87% | 76.74% | 83.38% | 78.49% | |
Intangible Assets out of Total Assets |
0.38 | 0.38 | 0.38 | 0.37 | |
Share Based Compensation of Revenue |
6.08% | 5.94% | 6.71% | 7.17% | |
Graham Net Nets |
0.16 | 0.18 | 0.22 | 0.23 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.40%) | (8.78%) | (10.59%) | (9.52%) | |
Free Cash Flow Yield |
0.20% | (0.86%) | (3.92%) | (4.34%) | |
Revenue per Share |
3.01 | 2.93 | 2.51 | 2.63 | |
Operating CF per Share |
0.19 | 0.04 | (0.14) | 0.44 | |
Capex per Share |
(0.12) | (0.17) | (0.07) | (0.03) | |
Free Cash Flow per Share |
0.07 | (0.13) | (0.21) | 0.42 | |
Cash per Share |
1.86 | 1.99 | 2.15 | 2.68 | |
Shareholders Equity per Share |
14.05 | 14.29 | 14.30 | 14.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.05 | 14.29 | 14.30 | 14.77 | |
Free Cash Flow |
1.60 | (3.12) | (5.05) | 9.75 | |
Working Capital |
197.61 | 199.66 | 198.68 | 210.22 | |
Capital Expenditures |
(2.91) | (4.04) | (1.76) | (0.60) | |
Net Current Asset Value |
83.50 | 84.73 | 82.39 | 94.39 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.06 | 0.03 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
55.41 | 57.37 | 49.21 | 48.10 | |
Average Payables |
15.82 | 17.46 | 16.95 | 13.85 | |
Average Inventory |
135.34 | 131.42 | 126.89 | 125.40 | |
Average Assets |
501.29 | 507.50 | 486.22 | 490.92 | |
Average Common Equity |
344.33 | 349.56 | 342.93 | 350.58 |
Columns are period end dates · fundamentals updated 2 Nov 2026